Merck & Company (MRK)
87.60 x 2 88.14 x 1
Post-market by (Cboe BZX)
87.60 -0.51 (-0.58%) 03/27/25 [NYSE]
87.60 x 2 88.14 x 1
Post-market 87.98 +0.38 (+0.43%) 19:47 ET
for Thu, Mar 27th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 64,168,000 | 60,115,000 | 59,283,000 | 48,704,000 | 41,518,000 |
| Cost of Goods | 15,193,000 | 16,126,000 | 17,411,000 | 13,626,000 | 13,618,000 |
| Gross Profit | 48,975,000 | 43,989,000 | 41,872,000 | 35,078,000 | 27,900,000 |
| Operating Expenses | 28,754,000 | 41,035,000 | 23,590,000 | 21,879,000 | 22,352,000 |
| Operating Income | 20,221,000 | 2,954,000 | 18,282,000 | 13,199,000 | 5,548,000 |
| Other Income | -285,000 | -1,065,000 | -1,838,000 | 680,000 | 315,000 |
| Pre-tax Income | 19,936,000 | 1,889,000 | 16,444,000 | 13,879,000 | 5,863,000 |
| Income Tax | 2,803,000 | 1,512,000 | 1,918,000 | 1,521,000 | 1,340,000 |
| Net Income Continuous | 17,133,000 | 377,000 | 14,526,000 | 12,358,000 | 4,523,000 |
| Net Income Discontinuous | N/A | N/A | N/A | 704,000 | 2,548,000 |
| Minority Interests | 16,000 | 12,000 | 7,000 | 13,000 | 4,000 |
| Net Income | $17,117,000 | $365,000 | $14,519,000 | $13,049,000 | $7,067,000 |
| EPS Basic Total Ops | 6.76 | 0.14 | 5.73 | 5.16 | 2.79 |
| EPS Basic Continuous Ops | 6.77 | 0.15 | 5.74 | 4.88 | 1.79 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.28 | 1.01 |
| EPS Diluted Total Ops | 6.74 | 0.14 | 5.71 | 5.14 | 2.78 |
| EPS Diluted Continuous Ops | 6.74 | 0.15 | 5.71 | 4.86 | 1.78 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.28 | 1.00 |
| EPS Diluted Before Non-Recurring Items | 7.65 | 1.51 | 7.48 | 6.02 | 5.94 |
| EBITDA(a) | $24,720,000 | $6,826,000 | $22,191,000 | $16,413,000 | $9,034,000 |